MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN HUMAN LIVER-TRANSPLANTS

被引:46
作者
STEINHOFF, G
机构
[1] Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, Hannover
关键词
D O I
10.1016/0168-8278(90)90264-R
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplantation is performed successfully across major HLA differences between donor and recipient. This may be influenced by the organ specific expression of major histocompatibility complex (MHC) molecules which determine the local immune reactivity and rejection response. The tissue expression of MHC molecules on parenchymal and infiltrating cells has been studied in transplanted human liver using monoclonal antibodies and immunohistological methods. A strong induction of class I (HLA-A,B,C; β2-microglobulin) and class II (HLA-DR,DQ,DP) MHC antigens was demonstrated on hepatocytes, bile duct epithelium and endothelial cells during rejection episodes and viral and bacterial infections. The massive induction of donor antigens on hepatocytes, bile ducts and endothelia forms part of, and may also augment, the rejection response. During quiescent states without infection or rejection after transplantation, however, a rather restricted expression of class I and class II donor MHC antigens is present. In addition, the donor Kupffer cells and interstitial dendritic cells are gradually replaced by recipient accessory cells expressing self-MHC molecules. The changes in antigen density and distribution of donor MHC alloantigens as the replacement of accessory cells capable of presenting antigens to T-lymphocytes may influence the course of immune reactivity and the rejection response in the liver. This may partly explain the favourable clinical course long after transplantation. Preliminary clinical investigations of the effect of HLA matching have shown a dualistic effect of the matching of class I or class II HLA antigens. The role of HLA matching in liver transplants in large clinical studies, with specific immunological testing however, remains to be investigated. This may lead to prospective HLA matching with wider organ availability and improved preservation time in the future. Further studies should investigate in detail the T-cell receptor-MHC interaction in liver tissue during rejection as well as other types of immune reaction. The analysis of the alloantigen expression in tissue and its modulation by different immunosuppressants and cytokines may be of diagnostic and therapeutic aid. © 1990.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 51 条
[21]   EXPRESSION OF IA-ANTIGEN ON EPIDERMAL-KERATINOCYTES IN GRAFT VERSUS HOST-DISEASE [J].
LAMPERT, IA ;
SUITTERS, AJ ;
CHISHOLM, PM .
NATURE, 1981, 293 (5828) :149-150
[22]   EXPRESSION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON DIFFERENT LIVER CELLULAR-COMPONENTS IN RAT AND MAN [J].
LAUTENSCHLAGER, I ;
HAYRY, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 14 (04) :421-426
[23]  
LECHLER RI, 1988, IMMUNOLOGY, P25
[24]   INTERFERON TREATMENT OF MICE - ENHANCED EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON LYMPHOID-CELLS [J].
LINDAHL, P ;
GRESSER, I ;
LEARY, P ;
TOVEY, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (04) :1284-1287
[25]   EPITHELIAL-CELLS EXPRESSING ABERRANT MHC CLASS-II DETERMINANTS CAN PRESENT ANTIGEN TO CLONED HUMAN T-CELLS [J].
LONDEI, M ;
LAMB, JR ;
BOTTAZZO, GF ;
FELDMANN, M .
NATURE, 1984, 312 (5995) :639-641
[26]  
MARKUS BH, 1988, TRANSPLANTATION, V46, P372
[27]   MASSIVE INDUCTION OF DONOR-TYPE CLASS-I AND CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN REJECTING CARDIAC ALLOGRAFTS IN THE RAT [J].
MILTON, AD ;
FABRE, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (01) :98-112
[28]  
NAGAFUCHI Y, 1985, LANCET, V1, P551
[29]  
NATALI PG, 1981, TRANSPLANTATION, V31, P75, DOI 10.1097/00007890-198101000-00017
[30]  
OPELZ G, 1989, TRANSPLANT P, V21, P794